CA2096970C - Anilide derivative - Google Patents

Anilide derivative

Info

Publication number
CA2096970C
CA2096970C CA002096970A CA2096970A CA2096970C CA 2096970 C CA2096970 C CA 2096970C CA 002096970 A CA002096970 A CA 002096970A CA 2096970 A CA2096970 A CA 2096970A CA 2096970 C CA2096970 C CA 2096970C
Authority
CA
Canada
Prior art keywords
compound
carbon atoms
group
acetamide
diisopropylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002096970A
Other languages
English (en)
French (fr)
Other versions
CA2096970A1 (en
Inventor
Masakazu Sato
Yutaka Kawashima
Katsuo Hatayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of CA2096970A1 publication Critical patent/CA2096970A1/en
Application granted granted Critical
Publication of CA2096970C publication Critical patent/CA2096970C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA002096970A 1990-11-26 1991-11-21 Anilide derivative Expired - Fee Related CA2096970C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPHEI-2-322136 1990-11-26
JP32213690 1990-11-26

Publications (2)

Publication Number Publication Date
CA2096970A1 CA2096970A1 (en) 1992-05-27
CA2096970C true CA2096970C (en) 1998-07-14

Family

ID=18140332

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002096970A Expired - Fee Related CA2096970C (en) 1990-11-26 1991-11-21 Anilide derivative

Country Status (11)

Country Link
US (1) US5475130A (OSRAM)
EP (1) EP0559898B1 (OSRAM)
JP (1) JP2650096B2 (OSRAM)
KR (1) KR0169501B1 (OSRAM)
AT (1) ATE137744T1 (OSRAM)
CA (1) CA2096970C (OSRAM)
DE (1) DE69119434T2 (OSRAM)
DK (1) DK0559898T3 (OSRAM)
ES (1) ES2088574T3 (OSRAM)
GR (1) GR3020257T3 (OSRAM)
WO (1) WO1992009572A1 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
CA2115915A1 (en) * 1992-07-20 1994-02-03 Kenji Hayashi Benzene derivatives
WO1995014463A1 (en) * 1993-11-25 1995-06-01 Taisho Pharmaceutical Co., Ltd. Composition of pharmaceutical preparation improved in peroral absorbability
FR2729665B1 (fr) * 1995-01-19 1997-04-18 Pf Medicament Nouveaux derives de glycylanilides, leur preparation et leur application en therapeutique
FR2741619B1 (fr) * 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
AU721698B2 (en) * 1997-04-01 2000-07-13 Taisho Pharmaceutical Co., Ltd. Agent for preventing ischemic heart diseases
CN1252714A (zh) * 1997-04-01 2000-05-10 大正制药株式会社 用于预防再狭窄的制剂
KR20040032969A (ko) * 2001-08-28 2004-04-17 상꾜 가부시키가이샤 안지오텐신 ｉｉ 수용체 길항제를 함유하는 의약 조성물
US20050119314A1 (en) * 2002-04-05 2005-06-02 Sankyo Company, Limited Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
WO2005051298A2 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
WO2006046593A1 (ja) * 2004-10-27 2006-05-04 Daiichi Sankyo Company, Limited ２以上の置換基を有するベンゼン化合物
US7935715B2 (en) * 2006-07-28 2011-05-03 Boehringer Ingelheim International Gmbh Compounds which modulate the CB2 receptor
BRPI0718515A2 (pt) * 2006-09-25 2013-11-19 Boehringer Ingelheim Int Compostos que modulam o receptor cb2
WO2009061652A1 (en) * 2007-11-07 2009-05-14 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US8178568B2 (en) * 2008-07-10 2012-05-15 Boehringer Ingelheim International Gmbh Sulfone compounds which modulate the CB2 receptor
NZ591111A (en) 2008-09-25 2013-08-30 Boehringer Ingelheim Int Sulfonyl compounds which selectively modulate the cb2 receptor
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
US8299103B2 (en) * 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
US8383615B2 (en) 2009-06-16 2013-02-26 Boehringer Ingelheim International Gmbh Azetidine 2-carboxamide derivatives which modulate the CB2 receptor
EP2480544A1 (en) * 2009-09-22 2012-08-01 Boehringer Ingelheim International GmbH Compounds which selectively modulate the cb2 receptor
WO2011088015A1 (en) 2010-01-15 2011-07-21 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
WO2011109324A1 (en) 2010-03-05 2011-09-09 Boehringer Ingelheim International Gmbh Tetrazole compounds which selectively modulate the cb2 receptor
WO2012012307A1 (en) 2010-07-22 2012-01-26 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the cb2 rece
EP2803668A1 (en) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878248A (en) * 1971-05-03 1975-04-15 Monsanto Co Substituted alpha, alpha-dichloro-methane-sulfenyl chlorides
JPS5439028A (en) * 1977-08-31 1979-03-24 Hokko Chem Ind Co Ltd Acetanilide derivatives and bactericides containing the same for agricultural and horticultural, uses
US4329363A (en) * 1978-09-08 1982-05-11 Merck & Co., Inc. Substituted mercapto acid amides and their use
US4623662A (en) * 1985-05-23 1986-11-18 American Cyanamid Company Antiatherosclerotic ureas and thioureas
FR2540495B1 (fr) * 1983-02-07 1986-02-14 Roussel Uclaf Nouveaux derives de o-mercaptopropanamide et de ses homologues, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
GB2149394B (en) * 1983-07-19 1986-09-24 American Cyanamid Co Ureas
US4859707A (en) * 1983-08-23 1989-08-22 Key Pharmaceuticals, Inc. Sulfur-substituted phenylacetamides
DE3674014D1 (de) * 1985-02-04 1990-10-18 Searle & Co Disubstituierte 4-hydroxyphenylthio-anilide.
ZA871597B (en) * 1986-03-24 1988-10-26 Warner Lambert Co Substituted anilides of oleic,linoleic,or linolenic acid as inhibitors of acyl-coa:cholestrol acyltransferase
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
EP0361365A1 (en) * 1988-09-30 1990-04-04 E.R. SQUIBB & SONS, INC. Aminobenzoic and aminocyclohexane-carboylic acid compounds, compositions, and their method of use
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)

Also Published As

Publication number Publication date
WO1992009572A1 (en) 1992-06-11
DE69119434T2 (de) 1996-09-12
EP0559898A4 (OSRAM) 1994-01-12
JP2650096B2 (ja) 1997-09-03
DE69119434D1 (de) 1996-06-13
GR3020257T3 (en) 1996-09-30
ATE137744T1 (de) 1996-05-15
EP0559898B1 (en) 1996-05-08
KR0169501B1 (ko) 1999-03-20
KR930702254A (ko) 1993-09-08
CA2096970A1 (en) 1992-05-27
EP0559898A1 (en) 1993-09-15
DK0559898T3 (da) 1996-08-19
ES2088574T3 (es) 1996-08-16
US5475130A (en) 1995-12-12

Similar Documents

Publication Publication Date Title
CA2096970C (en) Anilide derivative
US5442110A (en) Hydroxamic acid derivative
RU2025123C1 (ru) Ингибиторы пролин- или лизингидроксилазы, фибро- или иммунодепрессанты, лечебное средство при расстройствах метаболизма коллагена или коллагеноподобных веществ
EP0347168B1 (en) Derivatives of p-substituted phenyl ester of pivalic acid
US5665777A (en) Biphenyl hydroxamate inhibitors of matrix metalloproteinases
EP1149063B1 (en) Ureido-thiobutyric acid derivatives as ppar-agonists
EP2482815B1 (en) Antiinflammatory 2-oxothiazoles and 2-oxooxazoles
EA007649B1 (ru) Ингибиторы гистондеацетилазы, вызывающие дифференцировку клеток, и их применение
WO2004110418A2 (en) Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
KR100417275B1 (ko) 2,3,5-트리메틸-4-히드록시아닐리드유도체,이의제조방법및이의치료용도
EP0463638A1 (en) Aminophenyl derivatives
KR20000069139A (ko) 프로테아제 억제제인 아미노구아니딘 및 알콕시구아니딘
JPH0662556B2 (ja) 新規アニリド
Hu et al. Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer’s disease
US4670469A (en) Hydroxamic acid and pharmaceutical preparations containing the same
US4981853A (en) Heterocyclic amides
EP1819669A2 (en) Novel inhibitors of histone deacetylase for the treatment of disease
JP2842147B2 (ja) Ａｃａｔ阻害剤
JPH05502233A (ja) 薬理学的に活性なアミドカルボキシレート誘導体
Bernstein et al. Synthesis and pharmacological characterization of a series of leukotriene analogs with antagonist and agonist activities
US5534533A (en) Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity
EP0121806B1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
JPH04173775A (ja) アニリド誘導体
US5872281A (en) Amino acid derivative having N,N-dialkylaminophenyl group
JPWO1992009572A1 (ja) アニリド誘導体

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20041122